Until now, we’ve blamed the poorer overall performance of the prefrontal cortex in these illnesses on the encompassing astrocyte pathology – says Oliveira – but this study right now supports the look at that astrocytes, targeted in a pathological process, can lead to neurodegeneration in a particular brain region actually. Psychiatric disease could be mimicked simply by affecting astrocytes! This is a fresh perspective on what these diseases can form totally, and consequently on how best to treat them. For the present time, while we usually do not test additional brain areas, Oliveira's email address details are specially relevant for disposition disorders diseases – depression, schizophrenia and bipolarity – which we realize to have both lack of cognitive functions, and abnormalities in the astrocytes of the prefrontal cortex.today announced closing of a previously announced sale of an aggregate of $15 million of securities in a authorized direct offering. The traders are Deerfield Management Firm and other institutional traders. BioSante received net proceeds of around $14.2 million after deducting positioning agent fees and other offering expenses. BioSante offered an aggregate of around 7.1 million shares of its common stock and warrants to get up to approximately 3.55 million shares of its common stock. Each device, consisting of one talk about of common share and a warrant to get 0.50 of a talk about of common share, was sold for a price of $2.1025, on Friday June 18 reduced to the closing bid cost, 2010, as reported by the NASDAQ CURRENCY MARKETS.